Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Sexual Dysfunction Male

Tundra lists 4 Sexual Dysfunction Male clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07385222

Extracorporeal Magnetic Innervation Plus Pelvic Floor Muscle Training for Premature Ejaculation

This single-center, prospective, parallel-group randomized controlled trial evaluated whether extracorporeal magnetic innervation (ExMI) added to pelvic floor muscle training (PFMT) improves pelvic floor muscle function and premature ejaculation symptoms compared with PFMT alone in men with premature ejaculation. Participants were assessed at baseline, week 4, and week 8 using real-time suprapubic ultrasonography and validated patient-reported outcome measures.

Gender: MALE

Ages: 18 Years - Any

Updated: 2026-09-11

1 state

Premature (Early) Ejaculation
Ejaculatory Dysfunction
Sexual Dysfunction Male
COMPLETED

NCT04512287

PRP for Treatment of Peyronie's Disease

The purpose of this study is to learn about the effects of Platelet-Rich Plasma (PRP) injection in men with Peyronie's Disease (PyD).

Gender: MALE

Ages: 18 Years - 75 Years

Updated: 2026-08-03

1 state

Peyronie Disease
Sexual Dysfunction, Physiological
Sexual Dysfunction Male
+1
NOT YET RECRUITING

NCT07460726

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

This study looks at how combined radiation and hormone therapy affects sexual function in men with a specific type of prostate cancer, before and after treatment.

Gender: MALE

Ages: 18 Years - 80 Years

Updated: 2026-03-10

1 state

Prostate Cancer (Adenocarcinoma)
Erectile Abnormalities
Sexual Dysfunction Male
RECRUITING

NCT05345418

Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency

Sexual functional deficiency affects largely the physical conditions, life and sexual quality of the patients. Hypogonadism affects about 4 to 5 million men in the US, and the incidence increases with age. In our recent phase I clinical trial, we have shown that intravenous adipose - derived MSC administration was safe in female and male patients with hormone deficiency. Post-transplantation sexual satisfaction was observed in all patients enrolled in this study. Testosterone levels in males increased significantly after transplantation and were maintained at high levels for up to 6 months before decreasing again at the 12-month follow-up. The aim of this clinical trial was to assess the safety and effectiveness of allogeneic administration of MSCs in middle-aged people with sexual functional deficiency.

Gender: MALE

Ages: 50 Years - 70 Years

Updated: 2024-06-04

Sexual Dysfunction Male